These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23266047)

  • 21. Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer.
    Matsusaka S; Suenaga M; Mishima Y; Takagi K; Terui Y; Mizunuma N; Hatake K
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):763-8. PubMed ID: 21170650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas.
    Papachristou DJ; Korpetinou A; Giannopoulou E; Antonacopoulou AG; Papadaki H; Grivas P; Scopa CD; Kalofonos HP
    Virchows Arch; 2011 Oct; 459(4):431-40. PubMed ID: 21769619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
    Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
    Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dicer and outcomes in patients with acute myeloid leukemia (AML).
    Martin MG; Payton JE; Link DC
    Leuk Res; 2009 Aug; 33(8):e127. PubMed ID: 19278725
    [No Abstract]   [Full Text] [Related]  

  • 25. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.
    Guiu B; Petit JM; Bonnetain F; Ladoire S; Guiu S; Cercueil JP; Krausé D; Hillon P; Borg C; Chauffert B; Ghiringhelli F
    Gut; 2010 Mar; 59(3):341-7. PubMed ID: 19837679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.
    Strimpakos A; Pentheroudakis G; Kotoula V; De Roock W; Kouvatseas G; Papakostas P; Makatsoris T; Papamichael D; Andreadou A; Sgouros J; Zizi-Sermpetzoglou A; Kominea A; Televantou D; Razis E; Galani E; Pectasides D; Tejpar S; Syrigos K; Fountzilas G
    Clin Colorectal Cancer; 2013 Dec; 12(4):267-274.e2. PubMed ID: 24050852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
    Shu GS; Yang ZL; Liu DC
    Pathol Res Pract; 2012 Jul; 208(7):392-7. PubMed ID: 22658478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients.
    Stratmann J; Wang CJ; Gnosa S; Wallin A; Hinselwood D; Sun XF; Zhang H
    BMC Cancer; 2011 Aug; 11():345. PubMed ID: 21827717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic Leukemia.
    Gelmez MY; Coskunpinar E; Saracoglu B; Deniz G; Aktan M
    Immunol Invest; 2017 Jul; 46(5):433-446. PubMed ID: 28388279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of microRNA processing enzymes Drosha and Dicer in gestational diabetes mellitus.
    Rahimi G; Jafari N; Khodabakhsh M; Shirzad Z; Dogaheh HP
    Gynecol Endocrinol; 2015 Feb; 31(2):156-9. PubMed ID: 25295740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in the Drosha and Dicer Cleavage Profiles in Colorectal Cancer and Normal Colon Tissue Samples.
    Shkurnikov MY; Nersisyan SA; Osepyan AS; Maltseva DV; Knyazev EN
    Dokl Biochem Biophys; 2020 Jul; 493(1):208-210. PubMed ID: 32894467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulated expression of dicer and drosha in breast cancer.
    Yan M; Huang HY; Wang T; Wan Y; Cui SD; Liu ZZ; Fan QX
    Pathol Oncol Res; 2012 Apr; 18(2):343-8. PubMed ID: 21898071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients.
    De Stefano A; Carlomagno C; Pepe S; Bianco R; De Placido S
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1207-13. PubMed ID: 21409384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab.
    Steffensen KD; Madsen CV; Andersen RF; Waldstrøm M; Adimi P; Jakobsen A
    Eur J Cancer; 2014 Oct; 50(15):2611-8. PubMed ID: 25087181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.
    Guijarro-Muñoz I; Sánchez A; Martínez-Martínez E; García JM; Salas C; Provencio M; Alvarez-Vallina L; Sanz L
    Med Oncol; 2013; 30(2):572. PubMed ID: 23579861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of dicer expression in ovarian cancer tissues.
    Pampalakis G; Diamandis EP; Katsaros D; Sotiropoulou G
    Clin Biochem; 2010 Feb; 43(3):324-7. PubMed ID: 19782670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab.
    Koukourakis MI; Giatromanolaki A; Sheldon H; Buffa FM; Kouklakis G; Ragoussis I; Sivridis E; Harris AL;
    Clin Cancer Res; 2009 Nov; 15(22):7069-76. PubMed ID: 19887481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
    Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
    Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.